Clinical Trials Logo

Clinical Trial Summary

The purpose of this study is to more rigorously evaluate the response to a single bolus of magnesium sulfate in a population of patients with moderate to severe bronchiolitis. The primary outcome will be to evaluate the effect of this therapy on clinical respiratory status. Secondary outcomes of interest will include the incidence of adverse effects and safety profile of magnesium bolus use in this population.


Clinical Trial Description

This randomized placebo-controlled pilot study is designed to evaluate the above referenced outcomes. Study drug initiation will occur in the local pediatric intensive care unit in patients with a clinical diagnosis of bronchiolitis and whose parent/LAR consents for their participation. Our goal is to enroll and evaluate a total of 40 patients. Upon obtaining informed consent, the participant will receive an enrollment history and physical to include: baseline Modified Pulmonary Index Score (MPIS), blood pressure, vital signs, and epidemiologic data. The participant will then receive either a bolus of 50mg/kg Magnesium Sulfate (MgSO4) or normal saline as placebo medication over twenty minutes. Vital signs and MPIS will be monitored according to the study schedule, for a total of six hours. During the period of monitoring subjects will not receive additional bronchodilators unless otherwise deemed clinically necessary by the subject's attending physician. If administered, these will be recorded by investigative team. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT04740294
Study type Interventional
Source University of Louisville
Contact
Status Active, not recruiting
Phase Phase 2/Phase 3
Start date July 21, 2021
Completion date July 1, 2025

See also
  Status Clinical Trial Phase
Recruiting NCT04989114 - Nasal Bubble Continuous Positive Airway Pressure in Reducing Respiratory Distress in Children With Bronchiolitis N/A
Recruiting NCT04287959 - SWISH Trial (Strategies for Weaning Infants on Supportive High Flow) N/A
Not yet recruiting NCT01618175 - Home Oxygen Treatment of Childhood Acute Bronchiolitis N/A
Completed NCT01247064 - Hypertonic Saline for Acute Bronchiolitis Phase 4
Completed NCT03062917 - Nasal and Bronchial Absorption Sampling in RSV Bronchiolitis N/A
Recruiting NCT06030505 - Effectiveness of Nirsevimab in Children Hospitalised With RSV Bronchiolitis
Completed NCT02571517 - Glucocorticoid Therapy Impact on the Inflammatory Response and Clinical Evolution in Patients With Severe Bronchiolitis Phase 4
Completed NCT02853838 - Chest Physiotherapy in Infants Between 0 and 12 Months Old With Acute Bronchiolitis SRV(+) N/A
Terminated NCT03252119 - High Flow Oxygen Therapy vs Standard Care in Infants With Viral Bronchiolitis N/A
Terminated NCT03959384 - Efficacy and Safety of Curosurf® in Patients Invasively Ventilated for Severe Bronchiolitis Under 12 Months of Age Phase 3
Completed NCT00119002 - The Effectiveness of Oral Dexamethasone for Acute Bronchiolitis Phase 4
Terminated NCT04221087 - Steroid Use in Non-RSV Bronchiolitis Phase 4
Recruiting NCT04764929 - Pediatric Helmet CPAP Pilot Study N/A
Completed NCT00122785 - Single Injection of Dexamethasone for Acute Bronchiolitis in Young Children N/A